How new Labour Codes could  strengthen pharma industry’s welfare framework – A Ziraat Times explainer 

Ziraat Times Team Report

New Delhi, Nov 26: The Government of India on Wednesday said the newly notified Labour Codes—particularly the Occupational Safety, Health and Working Conditions (OSHWC) Code, 2020—have created a modern, unified safety and welfare framework for the fast-evolving pharmaceutical sector, replacing decades-old fragmented rules.

According to an official statement, the OSHWC Code and the Social Security Code, 2020 now place the drugs and pharmaceutical industry under a consolidated regulatory system designed to address advanced chemical, biological, and process hazards in modern pharma manufacturing.

Unified Safety Governance for a Changing Industry

The pharmaceutical sector, formerly regulated under multiple provisions of the Factories Act, has expanded beyond traditional chemical processing to high-potency drug synthesis, vaccine and biologics manufacturing, oncology compounds, biosafety laboratories, and nano-material handling.

The government said this changing landscape required a modernised regulatory architecture. The OSHWC Code, 2020 integrates and strengthens earlier hazardous-process rules and extends oversight to emerging risks such as:

  • Biological agents and cytotoxic substances

  • Mutagenic and teratogenic compounds

  • Robotics and AI-enabled production lines

  • Clean-room sterility controls

  • Nano-materials and recombinant DNA operations

Enhanced Risk Management and Surveillance

Under the new safety framework, pharma units are required to implement:

  • Scientific risk assessments and biosafety containment

  • Process Hazard Analysis (PHA) and exposure monitoring

  • Environmental and workplace surveillance

  • Digital health records

  • Mandatory medical examinations—pre-employment, periodic, post-incident and annual—for workers handling hazardous substances

These measures aim to prevent occupational illnesses such as respiratory sensitisation, reproductive health impacts, dermatological disorders and chemical toxicity.

Streamlined Compliance, Stronger Emergency Readiness

The Codes introduce simplified compliance processes for employers through:

  • Single-window licensing

  • Risk-based inspections

  • Digitised returns and record-keeping

  • Centralised clearances

Emergency preparedness has also been strengthened by mandatory on-site emergency plans, mock drills, spill-response systems, and trained incident-command structures.

Competency-Based Certification and Safety Culture

To improve workforce competence, the OSHWC Code mandates:

  • Certification for handling hazardous chemicals, biologics and clean-room systems

  • Participation of workers in safety committees

  • Transparent accident reporting

  • Empowerment of safety officers

These provisions aim to build a participatory safety culture in pharma manufacturing environments.

Support for Women in Pharma Workplaces

The Codes introduce additional safeguards for pregnant and lactating women working in sensitive environments such as sterile zones, automated labs and biologics units, further expanding opportunities for women in high-skill pharma roles.

Expanded Social-Security Net for Workers

The Social Security Code, 2020 guarantees:

  • Universal ESI coverage

  • Recognition of occupational diseases

  • Disability and dependents’ benefits

  • Maternity entitlements

The government said the combined reforms create a stronger health-economic safety net for the sector’s workforce.

Government Says Reforms Will Boost Productivity and Global Competitiveness

The statement noted that the four consolidated Labour Codes mark a shift from reactive compliance to prevention-driven, technology-enabled governance. The pharmaceutical industry—central to India’s role as a global supplier of medicines and vaccines—is expected to benefit through higher productivity, reduced workplace morbidity, and elevated investor confidence.

The government said the new framework “reinforces India’s position as a global pharmacy and biotechnology manufacturing hub” and aligns with the national vision of building safer, more competitive and worker-centric industrial systems.